Back to User profile » Mr Hiroshi Yoshitani
Paper published by Mr Hiroshi Yoshitani:
Original Research
Post-Marketing Surveillance Study of the Safety and Efficacy of Nalfurafine (Capsules 2.5 μg, Oral Dispersing Tablets 2.5 μg) in 1186 Patients with Chronic Liver Disease and Intractable Pruritus
Yoshitani H, Ito J, Kozono H
Hepatic Medicine: Evidence and Research 2022, 14:37-66
Published Date: 2 May 2022